Patient Satisfaction, Safety, and Efficacy of Endovenous Laser Treatment for Saphenous Veins and Varicose Veins

This is a non-interventional, prospective, non-randomized, descriptive, and multicenter study.

The study will be conducted by vascular physicians practicing at the Institute of Vascular Pathology of the Geoffroy Saint-Hilaire Private Hospital or La Muette Clinic (Paris).

The study population will be composed of adult patients receiving routine care for Endovenous Laser Ablation of primary or recurrent saphenous vein (great saphenous vein, small saphenous vein or anterior saphenous vein) outside the operating theater under strict local anesthesia.

• Endovenous laser ablation of the primary or recurrent saphenous vein (Procedure): Treatment of saphenous veins and varicose veins performed outside the operating room strictly under local anesthesia with a 1940 nm laser.

Primary outcomes

• Venous Treatment Satisfaction Questionnaire early score [12 days]: Evaluate the post-operative patient satisfaction on the treatment of saphenous veins and varicose veins outside the operating theater under strict local anesthesia with a 1940 nm laser via the Venous Treatment Satisfaction Questionnaire early. Scale from 0 to 6 (a high score indicates a positive result).

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Age ≥ 18 years.
* Endovenous Laser Ablation of a common or recurrent saphenous vein as part of routine care.
* Clinical, Etiology, Anatomy, Pathophysiology, classification clinical stage.
* Ability to understand the study objectives and complete questionnaires in French.
* Patient has been informed and has verbally indicated their non-opposition to participating in the research.

Exclusion Criteria:

* Endovenous Laser Ablation not feasible for technical reasons, particularly if the vein is too "bent" or there are endoluminal obstacles.
* Episode of deep vein thrombosis less than 3 months ago or of superficial vein thrombosis less than 6 weeks ago.
* Active cancer.
* Geographical distance incompatible with study follow-up, according to the investigator's judgment.
* Patients currently participating or having participated in research within the previous 3 months.
* Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code (corresponds to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure).